These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12828670)

  • 21. Adjusted dose continuous infusion of factor VIII in patients with haemophilia A.
    Martinowitz U; Schulman S; Gitel S; Horozowski H; Heim M; Varon D
    Br J Haematol; 1992 Dec; 82(4):729-34. PubMed ID: 1482660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The "OPTI-CLOT" trial. A randomised controlled trial on periOperative PharmacokineTIc-guided dosing of CLOTting factor concentrate in haemophilia A.
    Hazendonk HC; van Moort I; Fijnvandraat K; Kruip MJ; Laros-van Gorkom BA; van der Meer FJ; Meijer K; Peters M; Schutgens RE; Zwaan CM; Driessens MH; Polinder S; Leebeek FW; Mathôt RA; Cnossen MH
    Thromb Haemost; 2015 Aug; 114(3):639-44. PubMed ID: 26062822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The safety of pharmacologic options for the treatment of persons with hemophilia.
    Franchini M; Mannucci PM
    Expert Opin Drug Saf; 2016 Oct; 15(10):1391-400. PubMed ID: 27367551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Substitution therapy of hemorrhagic diseases].
    Haupt H
    Anasthesiol Intensivmed Prax; 1975 Oct; 11(1):137-44. PubMed ID: 1225069
    [No Abstract]   [Full Text] [Related]  

  • 25. Factor VIII pharmacokinetics: intermittent infusion versus continuous infusion.
    Morfini M; Messori A; Longo G
    Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S11-4. PubMed ID: 8735791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No inhibitor development after continuous infusion of factor concentrates in subjects with bleeding disorders undergoing surgery: a prospective study.
    Auerswald G; Bade A; Haubold K; Overberg D; Masurat S; Moorthi C
    Haemophilia; 2013 May; 19(3):438-44. PubMed ID: 23279056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequential therapy with activated prothrombin complex concentrate (FEIBA) and recombinant factor VIIa in a patient with severe haemophilia A, inhibitor presence and refractory bleeding.
    Economou M; Teli A; Tzantzaroudi A; Tsatra I; Zavitsanakis A; Athanassiou-Metaxa M
    Haemophilia; 2008 Mar; 14(2):390-1. PubMed ID: 18194305
    [No Abstract]   [Full Text] [Related]  

  • 28. Continuous infusion of monoclonal antibody-purified factor VIII.
    Weinstein RE; Bona RD; Rickles FR
    Am J Hematol; 1991 Mar; 36(3):211-2. PubMed ID: 1899966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lingual hemorrhage in a patient with hemophilia A complicated by a high titer inhibitor. Management by continuous infusion of monoclonal antibody-purified factor VIII.
    Gordon EM; Mungo R; Goldsmith JC
    Am J Pediatr Hematol Oncol; 1993 Feb; 15(1):107-10. PubMed ID: 8447550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Successful treatment with continuous infusion of coagulation factor concentrates in severe hemophilia A complicated with mixed trauma, crush syndrome and acute renal failure].
    Griniūte R; Gerbutavicius R; Pilvinis V; Pamerneckas A
    Medicina (Kaunas); 2005; 41(10):857-60. PubMed ID: 16272833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma-derived biological medicines used to promote haemostasis.
    Ofosu FA; Freedman J; Semple JW
    Thromb Haemost; 2008 May; 99(5):851-62. PubMed ID: 18449414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective audit of a continuous infusion protocol for haemophilia A at a single haemophilia treatment centre.
    Mulcahy R; Walsh M; Scully MF
    Haemophilia; 2005 May; 11(3):208-15. PubMed ID: 15876265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous infusion of B-domain deleted recombinant factor VIII (ReFacto) in patients with haemophilia A undergoing surgery: clinical experience.
    Stieltjes N; Altisent C; Auerswald G; Négrier C; Pouzol P; Reynaud J; Roussel-Robert V; Savidge GF; Villar A; Schulman S
    Haemophilia; 2004 Sep; 10(5):452-8. PubMed ID: 15357770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regimens of factor VIII administration--continuous infusion vs. bolus.
    Berntorp E
    Haematologica; 2000 Oct; 85(10 Suppl):69-71; discussion 71-2. PubMed ID: 11187875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimizing factor prophylaxis for the haemophilia population: where do we stand?
    Blanchette VS; Manco-Johnson M; Santagostino E; Ljung R
    Haemophilia; 2004 Oct; 10 Suppl 4():97-104. PubMed ID: 15479380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylactic treatment with FEIBA of a haemophilia A patient with inhibitor: what are the costs, what are the benefits?
    Siegmund B; Richter H; Pollmann H
    Haemophilia; 2005 Nov; 11(6):638-41. PubMed ID: 16236116
    [No Abstract]   [Full Text] [Related]  

  • 37. Successful induction of immune tolerance by continuous infusion of recombinant factor VIII in a haemophilia A patient with high-inhibitor titres.
    Tamura K; Kanazawa T; Suzuki M; Shioya A; Morikawa A
    Haemophilia; 2006 Jan; 12(1):100-2. PubMed ID: 16409184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous infusion of factor VIII for surgery and major bleeding.
    Hay CR; Doughty HI; Savidge GF
    Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S15-9. PubMed ID: 8735792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Continuous infusion of coagulant factor concentrates and its pharmacokinetics in patients with hemophilics having low titer inhibitor].
    Fujii T; Takata N; Kimura A
    Rinsho Ketsueki; 2007 Apr; 48(4):321-5. PubMed ID: 17515124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Editorial: Factor VIII inhibitors.
    Deykin D
    N Engl J Med; 1974 Jul; 291(4):205. PubMed ID: 4834491
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.